Back
Protalix BioTherapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
71
PLX
Protalix BioTherapeutics
Last Price:
$1.80
Seasonality Move:
19.62%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.75 | Buy |
| 20-day SMA: | 1.73 | Buy |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 1.21 | Buy |
| 8-day EMA: | 1.76 | Buy |
| 20-day EMA: | 1.71 | Buy |
| 50-day EMA: | 1.53 | Buy |
| 200-day EMA: | 1.33 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 63.49 | Buy |
| Chaikin Money Flow: | -116103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.66 - 1.78) | Buy |
| Bollinger Bands (100): | (0.94 - 1.54) | Buy |
Protalix BioTherapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.78 while PLX 8-day simple moving average is 1.75, which is a Buy signal.
-
The stock price of PLX is 1.78 while Protalix BioTherapeutics 20-day SMA is 1.73, which makes it a Buy.
-
Protalix BioTherapeutics 50-day simple moving average is 1.47 while PLX share price is 1.78, making it a Buy technically.
-
PLX stock price is 1.78 and Protalix BioTherapeutics 200-day simple moving average is 1.21, creating a Buy signal.
PLX Technical Analysis vs Fundamental Analysis
Buy
71
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a BuyThe current Protalix BioTherapeutics [PLX] share price is $1.78. The Score for PLX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
131.1M
Price in USD:
1.78
Share Volume:
215.6K
Protalix BioTherapeutics 52-Week Range
52-Week High:
1.87
52-Week Low:
0.82
Buy
71
Protalix BioTherapeutics (PLX)
is a Buy
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 1.78 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is not overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.78 while PLX 8-day exponential moving average is 1.76, which is a Buy signal.
-
The stock price of PLX is 1.78 while Protalix BioTherapeutics 20-day EMA is 1.71, which makes it a Buy.
-
Protalix BioTherapeutics 50-day exponential moving average is 1.53 while PLX share price is 1.78, making it a Buy technically.
-
PLX stock price is 1.78 and Protalix BioTherapeutics 200-day simple moving average is 1.33, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Protalix BioTherapeutics is a Buy
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 63.49, which suggest Protalix BioTherapeutics is overbought
-
The Bollinger Bands (25) for Protalix BioTherapeutics is (1.66 - 1.78), which suggest Protalix BioTherapeutics is a Buy
-
The Bollinger Bands (100) for Protalix BioTherapeutics is (0.94 - 1.54), which suggest Protalix BioTherapeutics is a Buy
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.